Boston Scientific · 2 months ago
Process Tech III - 1st Shift
Maple Grove, MN
Full-time
Onsite
Mid Level
$54K/yr - $91K/yr
3+ years expBoston Scientific is a leader in medical science, dedicated to solving important health industry challenges. The Process Tech III role involves coordinating and tracking pilot builds for new product development projects, collaborating with cross-functional teams to ensure timely execution, and managing resources effectively.
Health CareMedicalMedical Device
No H1B
Responsibilities
Coordinate and track pilot builds for new product development projects
Collaborate with cross-functional teams and production environments to ensure smooth and timely execution of pilot builds
Identify and resolve potential issues that may arise during pilot builds
Communicate progress and any challenges to project stakeholders
Develop and maintain project timelines and ensure all milestones are met
Monitor and manage resources (people, materials) for pilot builds
Conduct risk assessments and implement contingency plans to mitigate potential delays or roadblocks
Update and maintain project documentation and records
Train and guide team members on pilot build processes and procedures
Ensure compliance with all relevant regulations and company policies
Continuously identify opportunities for process improvement and implement changes as needed
Prioritize and manage multiple tasks and likely projects, simultaneously
Foster a positive and collaborative work environment to drive team success
Qualification
Required
3 years of experience with a high school diploma/degree/equivalent, or an equivalent combination of education/work experience
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Leadership Team
Michael Mahoney
Chairman, President & CEO
Daniel J. Brennan
Chief Financial Officer
Recent News
2026-01-24
2026-01-23
Company data provided by crunchbase